Endocarditis: History and Discovery

The story of endocarditis — inflammation of the heart's inner lining and valves — spans four centuries. Anatomists of the 1600s first glimpsed strange growths on the valves of the dead; a French clinician named the disease in the early nineteenth century; bacteriologists of the late 1800s discovered that living germs lay at its heart; and William Osler, in his celebrated 1885 Gulstonian Lectures, drew clinic, autopsy table, and microscope together into a single coherent picture. For most of that history the diagnosis was a death sentence. Only with penicillin in the 1940s did endocarditis become a disease that medicine could actually cure — one of the great turning points in the history of heart medicine. This page traces that long arc, with care taken to distinguish who named the disease, who described it, and who first proved its cause.

First Glimpses: Valve Vegetations in the 17th and 18th Centuries
Naming the Disease: Corvisart, Laennec, and Bouillaud
Bouillaud and the Rheumatic-Fever Connection
The Germ Hunters: Winge, Heiberg, Klebs, and Schottmüller
William Osler and the 1885 Gulstonian Lectures
The Peripheral Signs: Osler Nodes, Janeway Lesions, and Libman
From Fatal to Curable: The Penicillin Revolution
The Modern Era: Echocardiography, the Duke Criteria, and Prophylaxis
Legacy: What the History Teaches
Research Papers and References
Connections

First Glimpses: Valve Vegetations in the 17th and 18th Centuries

The earliest reasonably clear description of what we now recognize as endocarditis comes from the French physician Lazare Rivière (Lazarus Riverius, 1589–1655), professor at the University of Montpellier. In a case recorded in 1646, Rivière described a patient who had died after an illness marked by irregular pulse and breathlessness; at autopsy he found, in the left ventricle and obstructing the opening of the aorta, firm growths he likened to "round carbuncles" or "a cluster of hazelnuts." Nearly two centuries later Laennec would credit this report as the first account of aortic-valve disease bearing the vegetations of endocarditis. Rivière could not have known what these growths were — the concept of infection lay two centuries in the future — but he had seen the disease's pathological signature.

Over the following century, anatomists slowly accumulated similar observations. Giovanni Maria Lancisi and Raymond de Vieussens recorded valve lesions, though without firm clinical correlation. The decisive figure was Giovanni Battista Morgagni (1682–1771), the Paduan founder of pathological anatomy, whose monumental De Sedibus et Causis Morborum ("On the Seats and Causes of Diseases," 1761) systematically matched patients' symptoms in life to the diseased organs found after death. Morgagni described valvular vegetations and chronic valve disease and, crucially, taught physicians to reason from the autopsy back to the bedside — the method on which the entire later understanding of endocarditis would be built.

It is important to be precise about what these early observers did and did not achieve. They saw and described the growths on the valves; they did not name the disease as a distinct inflammatory entity, and they had no notion of its cause. Those steps belonged to the nineteenth century, and to a remarkable generation of Paris physicians.

Back to Table of Contents

Naming the Disease: Corvisart, Laennec, and Bouillaud

The early nineteenth-century Paris school transformed medicine by uniting careful bedside observation with systematic autopsy. Jean-Nicolas Corvisart (1755–1821), Napoleon's personal physician and the man who revived the technique of chest percussion, introduced in 1806 the term végétations ("vegetations") for the soft excrescences he found loosely attached to diseased heart valves — a word still used at the bedside and in the operating theatre today. His pupil René-Théophile-Hyacinthe Laennec (1781–1826), the inventor of the stethoscope, refined the description further, distinguishing different forms of valvular vegetation in his great treatise on auscultation.

The decisive act of naming belongs to Jean-Baptiste Bouillaud (1796–1881). In his early monographs of 1824–1825, Bouillaud introduced the twin terms endocarde ("endocardium," for the inner lining of the heart and its valves) and endocardite ("endocarditis," for inflammation of that lining). Both words passed essentially unchanged into every language of medicine and are the names we still use. Bouillaud thus did for the inside of the heart what others had done for the lung and the gut: he defined a tissue and named the disease that inflames it.

A point of historical accuracy is worth flagging here, because dates differ across sources. Bouillaud coined the terms in the mid-1820s; his fuller, more famous synthesis — the Traité clinique des maladies du cœur, which described the stages of endocarditis in detail and is sometimes cited simply as "~1835" — came roughly a decade later. Both statements are correct: the word dates to 1824–1825, the mature clinical treatise to 1835. Either way, the term "endocarditis" is Bouillaud's, and it is one of the most durable coinages in the whole vocabulary of cardiology.

Back to Table of Contents

Bouillaud and the Rheumatic-Fever Connection

Bouillaud's second great contribution was clinical rather than terminological, and it shaped cardiology for more than a century. Studying patients with acute rheumatism, he observed that inflammation of the heart — of both the endocardium (endocarditis) and the surrounding sac (pericarditis) — accompanied attacks of acute articular rheumatism so often that the association could not be coincidence. He framed this as a "law of coincidence" between acute rheumatism and inflammation of the heart, published in the 1830s and 1840s. In plain terms, Bouillaud recognized that what we now call rheumatic fever frequently attacks the heart valves.

This insight mattered enormously, because rheumatic fever — an immune reaction to streptococcal throat infection — was, for generations, the leading cause of the scarred, deformed heart valves on which infective endocarditis later took hold. The chain that nineteenth- and twentieth-century physicians came to understand ran like this: a strep throat in childhood could trigger rheumatic fever; rheumatic fever could scar a heart valve; and a scarred valve was fertile ground on which wandering bacteria in the bloodstream could later settle and grow. Bouillaud had identified the first link in that chain.

The relationship between rheumatic fever, damaged valves, and subsequent infection became one of the organizing ideas of classic cardiology. It is also why the dramatic decline of rheumatic fever in wealthy countries — thanks to antibiotics for strep throat and better living conditions — changed the very face of endocarditis over the twentieth century, shifting it away from young people with rheumatic valves toward older patients, people with prosthetic valves, and those who inject drugs.

Back to Table of Contents

The Germ Hunters: Winge, Heiberg, Klebs, and Schottmüller

Through the first half of the nineteenth century, endocarditis was understood as a purely inflammatory or even "chemical" process; the idea that living organisms might cause it did not yet exist. That changed with the rise of germ theory. William Senhouse Kirkes had shown in 1852 that fragments of valve vegetations could break loose and travel in the bloodstream to lodge in distant organs — the phenomenon of embolism, which explained the strokes, infarcts, and abscesses that so often accompanied the disease. But what were these vegetations made of?

The first to point at microbes were two Norwegians. In 1869, the Christiania (Oslo) physician Emanuel Winge proposed that "parasitic" particles within a valve vegetation were the cause of a fatal case, and in 1872 his colleague Hjalmar Heiberg described chains of cocci — that is, bacteria — within the vegetations themselves. These were, importantly, hypotheses and observations at the dawn of bacteriology; they marked a turning point in thinking even though the full proof came later. In 1878, the influential pathologist Edwin Klebs went further, proposing that endocarditis was fundamentally an infectious disease caused by microorganisms — a bold claim that subsequent decades would vindicate.

The bacteriological picture was completed in the early twentieth century. In 1910, the German physician Hugo Schottmüller described the slow, smoldering form of the disease he called endocarditis lenta ("slow endocarditis") and tied it firmly to infection with low-virulence streptococci of the viridans group. Schottmüller's work, together with the new ability to grow bacteria from a patient's blood, finally established that this was a treatable infection in waiting — if only an effective treatment could be found.

Back to Table of Contents

William Osler and the 1885 Gulstonian Lectures

If one moment defines the modern understanding of endocarditis, it is Sir William Osler's Gulstonian Lectures, "On Malignant Endocarditis," delivered before the Royal College of Physicians of London in 1885 and published the same year in the British Medical Journal. Osler (1849–1919), a Canadian who would become the most celebrated physician of his age and a founding professor of the Johns Hopkins Hospital, was then in his thirties. He took the scattered threads — the autopsy findings of the anatomists, the new bacteriological observations, the embolic complications, the varied clinical course — and wove them into the first comprehensive account in English of infective endocarditis as a coherent disease.

Before Osler, endocarditis was largely a diagnosis made after death, on the autopsy table. Osler's achievement was to describe the living disease: its insidious fevers, its murmurs, its embolic showers, its bacterial basis, and its grim natural history. He unified the clinical, the pathological, and the bacteriological into a single picture that physicians at the bedside could actually use. He returned to the subject repeatedly over the next thirty years, and his name became so bound to the disease that the eponym "Osler nodes" honors not a claim of first discovery but his decades-long mastery of the field.

It is fair, and historically honest, to call the Gulstonian Lectures the landmark synthesis of infective endocarditis rather than a discovery of any single fact. Osler did not isolate the germ, name the disease, or first see the vegetations; he did something arguably more useful for patients — he made the whole subject intelligible. That is why his 1885 lectures remain the hinge on which the history of this disease turns.

Back to Table of Contents

The Peripheral Signs: Osler Nodes, Janeway Lesions, and Libman

Because endocarditis showers bacteria and immune debris into the bloodstream, it announces itself through telltale marks on the skin — signs that became diagnostic landmarks and acquired famous names. Osler nodes are small, tender, raised reddish-purple lesions on the pads of the fingers and toes, reflecting the body's immune reaction to the infection. Osler highlighted them in his lectures of the 1880s and 1900s, and although he generously credited earlier observers with first noticing them, the eponym stuck to him.

Janeway lesions — flat, painless, reddish spots on the palms and soles, caused by tiny septic emboli — are named for the American physician Edward Gamaliel Janeway (1841–1911), a contemporary of Osler who described such skin findings in endocarditis patients in a paper of 1899. (The eponym is sometimes mistakenly attached to his equally distinguished son, Theodore Caldwell Janeway; the lesions trace to the father's observations.) The term "Janeway lesions" was popularized somewhat later, notably by Emanuel Libman, who attached the name in his writings of the 1900s and 1920s.

Emanuel Libman (1872–1946) of New York's Mount Sinai Hospital deserves special note. With Herbert Celler he published, in 1909–1910, a careful clinical and bacteriological study of subacute bacterial endocarditis, documenting through blood cultures the consistent presence of viridans streptococci and describing the disease's long, wasting course. Libman became the great American authority on the condition — he famously diagnosed it in the composer Gustav Mahler in 1911 — and in 1924, with Benjamin Sacks, he described a distinct, non-infective verrucous endocarditis associated with what is now called systemic lupus erythematosus, the entity still known as Libman–Sacks endocarditis. Distinguishing this sterile, immune-mediated form from true infective endocarditis remains clinically important to this day.

Back to Table of Contents

From Fatal to Curable: The Penicillin Revolution

For all the brilliance of the diagnosticians, the brutal fact of endocarditis before the 1940s was simple: it was almost uniformly fatal. Once bacteria established themselves on a heart valve, no treatment could reliably dislodge them. The subacute form — Schottmüller's endocarditis lenta, Libman's subacute bacterial endocarditis — killed slowly over months; the acute form killed fast. Physicians could name the disease, hear its murmurs, culture its germ, and predict its course with grim accuracy, but they could not save the patient. It is hard to overstate how much that helplessness shaped the disease's reputation as one of medicine's most feared.

The discovery of penicillin changed everything. Alexander Fleming had observed the mold's antibacterial effect in 1928, and the Oxford team of Howard Florey, Ernst Chain, and Norman Heatley turned it into a usable drug in the early 1940s. Endocarditis became one of the first proving grounds for the new antibiotic. In 1944–1945, physicians including Loewe and colleagues in New York reported curing patients with subacute bacterial endocarditis using penicillin (often combined with heparin) — results that were, for a disease previously regarded as a death sentence, nothing short of miraculous. A condition that had been essentially 100% fatal could now be cured in a large majority of cases.

Clinicians soon learned the principles that still govern treatment today: endocarditis requires high doses of antibiotics given intravenously for a prolonged course — typically weeks — because the bacteria are buried deep within a vegetation where the bloodstream barely reaches them. For tougher organisms such as enterococci, combining penicillin with streptomycin (and later gentamicin) proved far more effective than either drug alone. The antibiotic era did not make endocarditis harmless — it remains a serious, sometimes deadly disease — but it converted a hopeless diagnosis into a treatable one, and that transformation stands among the signal achievements of twentieth-century medicine.

Back to Table of Contents

The Modern Era: Echocardiography, the Duke Criteria, and Prophylaxis

The later twentieth century added the tools that define how endocarditis is diagnosed and managed today. Foremost was echocardiography — the use of ultrasound to image the beating heart. For the first time, physicians could actually see a vegetation on a valve in a living patient, rather than inferring it from fevers and murmurs or confirming it only at autopsy. Transthoracic echocardiography, and especially the more sensitive transesophageal echocardiography developed in the 1980s, made the bedside diagnosis of endocarditis vastly more reliable and remain central to modern care.

To bring order to a notoriously protean disease, David Durack and colleagues at Duke University published the Duke criteria in 1994, a structured diagnostic scheme that combined "major" criteria (positive blood cultures with typical organisms; echocardiographic evidence of valve involvement) with "minor" criteria (fever, predisposing heart conditions, vascular and immune phenomena such as Janeway lesions and Osler nodes). The Duke criteria markedly improved diagnostic accuracy over the older von Reyn scheme, were refined as the modified Duke criteria in 2000, and updated again in 2023; they remain the international standard for diagnosing infective endocarditis.

A final modern thread is prophylaxis — giving preventive antibiotics before certain dental or surgical procedures to patients with high-risk hearts, on the theory of heading off the bloodstream bacteria that could seed a valve. Guidelines from bodies such as the American Heart Association once recommended this broadly, but over the 2000s the recommendations were sharply narrowed to only the highest-risk patients (for example, those with prosthetic valves or prior endocarditis), reflecting better evidence about who truly benefits. The evolution of prophylaxis guidance shows that the history of endocarditis is still being written — refined continuously as new data arrive.

Back to Table of Contents

Legacy: What the History Teaches

The history of endocarditis is a compressed history of modern medicine itself. It begins with pure observation — seventeenth- and eighteenth-century anatomists describing growths they could not explain. It passes through the great age of naming and classifying, when Corvisart, Laennec, and above all Bouillaud gave the disease its vocabulary and tied it to rheumatic fever. It moves into the bacteriological revolution, when Winge, Heiberg, Klebs, and Schottmüller revealed that living germs lay behind the lesions. It reaches its great synthesis with Osler, who made the whole disease comprehensible. And it culminates in the therapeutic triumph of penicillin, which turned a death sentence into a curable infection.

Each phase illustrates a different way that medical knowledge advances: by looking, by naming, by discovering causes, by integrating, and finally by intervening. The eponyms that survive — Osler nodes, Janeway lesions, Libman–Sacks endocarditis — are not merely names to memorize but signposts to the people and moments that built our understanding. They remind us that behind every "classic sign" stands a real clinician who first noticed something at a real bedside.

For the patient today, this long history has a hopeful meaning. A disease that was, within living memory, almost always fatal is now diagnosable with ultrasound, classifiable with validated criteria, and curable with the right antibiotics — and, for the highest-risk hearts, sometimes preventable altogether. That arc — from Rivière's "cluster of hazelnuts" in 1646 to the modern coronary care unit — is one of the most encouraging stories cardiology has to tell.

Back to Table of Contents

Research Papers and References

The references below combine peer-reviewed historical reviews of infective endocarditis with curated PubMed topic-search links into the primary literature on each figure and milestone discussed above. Historical primary texts — Rivière's case of 1646, Morgagni's De Sedibus (1761), Bouillaud's monographs, and Osler's 1885 Gulstonian Lectures — are named in the article as historical sources. Links open at the National Library of Medicine (PubMed / PMC) in a new tab.

Lee D, Dempster J. Infective endocarditis: a history of the development of its understanding. Br J Cardiol. 2017. — PMC5453655 (full historical review)
Osler W. The Gulstonian Lectures, on Malignant Endocarditis. British Medical Journal. 1885;1(1262):467–470. — PMID 20751186
Geibel A, et al. Centenary of William Osler's 1885 Gulstonian lectures and their place in the history of bacterial endocarditis. J R Soc Med. 1985;78(12):1013–1017. — PMID 3906124
Roguin A. William Osler and his Gulstonian lectures on malignant endocarditis. — PMID 7033681
Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345(18):1318–1330. — doi:10.1056/NEJMra010082
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings (Duke criteria). Am J Med. 1994;96(3):200–209. — PMID 8154508
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638. — doi:10.1086/313753
Libman E, Celler HL. The etiology of subacute infective endocarditis. Am J Med Sci. 1910;140:516. — PMID 4579078
Lazare Rivière (1589–1655): the first modern description of aortic-valve failure with vegetations. — PMID 25851147
Bouillaud and the history of acute rheumatism and endocarditis ("law of coincidence"). — PubMed: Bouillaud endocarditis rheumatism history
Schottmüller and endocarditis lenta / viridans streptococci — historical bacteriology. — PubMed: Schottmüller endocarditis lenta history
Osler nodes and Janeway lesions — eponyms and historical descriptions in infective endocarditis. — PMID 18082531
Penicillin and the antibiotic treatment of bacterial endocarditis — history of cure. — PubMed: penicillin history bacterial endocarditis
Antibiotic prophylaxis for endocarditis — evolution of guidelines (AHA / ESC). — PubMed: endocarditis prophylaxis guidelines history

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents